Research

ATHLETE

Advancing Tools for Human Early Lifecourse Exposome Research and Translation

Duration
2020-2024
Coordinator
Martine Vrijheid (ISGlobal)
Funded by
European Union (EU) - Horizon 2020

The earliest parts of the life course are particularly vulnerable to environmental hazards and thus form an important starting point for the development of advanced exposome tools and data.

ATHLETE will establish a prospective exposome cohort, including a FAIR data infrastructure, by building on Europe’s most comprehensive exposome cohorts covering the first 18 years of life. Innovative exposure science and statistical tools will be used to systematically quantify the effects of the early life exposome (urban, chemical, physical, behavioural, and social risk factors) on early organ development, mental/respiratory/cardiometabolic health trajectories, and associated biological pathways, from early pregnancy through adolescence.

Knowledge translation will rely on the development of interventions to reduce personal exposures, estimation of the societal impact of the exposome in childhood, recommendations to underpin policy, and an open-access exposome toolbox.

Budget

11.998.333,75 euros

Our Team

Principal Investigator (PI)

  • Martine Vrijheid
    Martine Vrijheid Head of the Childhood and Environment Programme, Research Professor

ISGlobal Team

See More

Other projects

See Past Projects

EGG/EAGLE

Early Genetics Growth/Early Genetics and Lifecourse Epidemiology

APACHE

Air Pollution, Autism spectrum disorders, and brain imaging in CHildren amongst Europe

LIFECYCLE

Early-life stressors and LifeCycle health

HERA

Integrating Environment and Health Research: a Vision for the EU

MOOD-COVID

Pre- and post-natal Maternal mental health and newbOrn neurOdevelopment during the COVID-19 panDemic

EUCAN-Connect

A federated FAIR platform enabling large-scale analysis of high-value cohort data connecting Europe and Canada in personalized health

OBERON

An integrative strategy of testing systems for identification of EDs related to metabolic disorders